Array BioPharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.12.24	ARRAY Technologies Appoints Keith Jennings As CFO (RTTNews)
06.06.24	Array Technologies Appoints Neil Manning As President And COO (RTTNews)
25.03.23	ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Array Technologies, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation - ARRY (PR Newswire)
20.03.23	ARRY EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Array Technologies, Inc. Investors to Inquire About Class Action Investigation - ARRY (PR Newswire)
02.03.23	Array Technologies Sees FY22 Revenues Above Estimates (RTTNews)
09.11.22	Pre-market Movers: MACK, IXHL, UPST, CARG, ELBM… (RTTNews)
11.05.22	Pre-market Movers: U, ELBM, RCUS, EVEX, INO… (RTTNews)
06.04.22	Pre-market Movers: DC, GTIM, BBAI, RKLY, MLTX… (RTTNews)
05.04.22	Array Technologies Q4 Revenue Beats Street, Strong Revenue Outlook; Shares Up 18% (RTTNews)
11.11.21	Array Technologies Q3 Loss Widens (RTTNews)
18.06.19	5 Top Gainers In Healthcare Sector (ARRY, SYBX, CRTX...) (RTTNews)
17.06.19	Pfizer To Acquire Array BioPharma In $11.4 Bln Deal - Quick Facts (RTTNews)
22.05.19	5 Top Gainers In Pharma Sector (ARRY, EQ, ARWR...) (RTTNews)
21.05.19	Array BioPharma Says BRAFTOVI + MEKTOVI + Cetuximab Meet Primary Endpoints (RTTNews)
07.05.19	EARNINGS SUMMARY: Details of Array BioPharma Inc. Q3 Earnings Report (RTTNews)
05.02.19	EARNINGS SUMMARY: Details of Array BioPharma Inc. Q2 Earnings Report (RTTNews)
23.01.19	Aphria In Focus, UBX To Report Phase I Data In Q2, RARE On Track (RTTNews)
15.01.19	First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch (RTTNews)
30.10.18	EARNINGS SUMMARY: Details of Array BioPharma Inc. Q1 Earnings Report (RTTNews)
14.08.18	EARNINGS SUMMARY: Details of Array BioPharma Inc. Q4 Earnings Report (RTTNews)
07.08.18	Array BioPharma Gets FDA Breakthrough Therapy Designation For BRAFTOVI (RTTNews)
30.07.18	European Medicines Agency's CHMP Says Yes To 7 Drugs, No To 1 (RTTNews)
13.07.18	Array: NCCN Recommends BRAFTOVI With MEKTOVI As Category 1 Treatment Option (RTTNews)
28.06.18	ACRX Gets EC Nod, AQXP Tanks As LEADERSHIP 301 Fails, ZSAN Catches Eye (RTTNews)
23.06.18	Array BioPharma Reports Phase 3 BEACON CRC Data; 62% Observed Overall Survival (RTTNews)
23.06.18	An Ear To The Pharma: 15 Stocks To Watch (AKAO, PTIE, ASNS…) (RTTNews)
18.06.18	Array BioPharma to Present Overall Survival Results from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant Colorectal Cancer at the... (PR Newswire)
04.06.18	Array BioPharma Provides Updated Results From Phase 3 Columbus Trial (RTTNews)
04.06.18	Array BioPharma Announces Additional Median Overall Survival Results of Encorafenib and Binimetinib in Patients with BRAF-mutant Advanced Melanoma (PR Newswire)
30.05.18	Array BioPharma To Present at the Jefferies 2018 Global Healthcare Conference (PR Newswire)
29.05.18	Biotech Stocks Facing FDA Decision In June (RTTNews)
16.05.18	Array BioPharma Announces Oral Presentation from the Pivotal Phase 3 COLUMBUS trial of the Combination of Encorafenib and Binimetinib in Patients with BRAF-mutant Melanoma at 2018 ASCO Annual Meeting (PR Newswire)
09.05.18	Array Biopharma To Present At The Bank Of America Merrill Lynch 2018 Health Care Conference (PR Newswire)
09.05.18	EARNINGS SUMMARY: Details of Array BioPharma Inc. Q3 Earnings Report (RTTNews)
09.05.18	Array BioPharma Reports Financial Results For The Third Quarter of Fiscal 2018 (PR Newswire)
30.04.18	Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2018 On May 9, 2018 (PR Newswire)
22.03.18	Array BioPharma Announces Publication of Detailed Phase 3 COLUMBUS Trial Data of Encorafenib and Binimetinib in Melanoma Patients in The Lancet Oncology (PR Newswire)
05.03.18	Array BioPharma To Present At The Cowen 38th Annual Healthcare Conference (PR Newswire)
07.02.18	Array BioPharma To Present At The LEERINK Partners 7th Annual Global Healthcare Conference (PR Newswire)
07.02.18	ARRY's COLUMBUS Turns Heads, ZFGN On Course, MNOV UP 66% YTD (RTTNews)
06.02.18	Array BioPharma Announces Results Of Phase 3 COLUMBUS Trial (RTTNews)
06.02.18	EARNINGS SUMMARY: Details of Array BioPharma Inc. Q2 Earnings Report (RTTNews)
06.02.18	Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2018 (PR Newswire)
06.02.18	Encorafenib and Binimetinib Combination Treatment Demonstrates 33.6 Month Median Overall Survival (OS) in Patients with BRAF-Mutant Melanoma in Phase 3 COLUMBUS Trial (PR Newswire)
30.01.18	Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2018 On February 6, 2018 (PR Newswire)
23.01.18	ARRY Shines A BEACON, So Long To JUNO And BIVV, Exciting Time Ahead For GEMP (RTTNews)
20.01.18	Combination of Encorafenib, Binimetinib and Cetuximab Demonstrated an 8 Month Median Progression-Free Survival in BRAF-Mutant Colorectal Cancer in Updated Safety Lead-In Results from BEACON Phase 3... (PR Newswire)
16.01.18	Array BioPharma to Present Updated Phase 3 BEACON CRC Safety Lead-In Results of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant Colorectal Cancer at the 2018... (PR Newswire)
23.12.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY (PR Newswire)
19.12.17	Array BioPharma Enters Into Clinical Trial Collaboration Agreement With Pfizer (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

06.02.25		Handel in Frankfurt: TecDAX auf grünem Terrain
06.02.25		Gewinne in Frankfurt: MDAX mittags mit grünem Vorzeichen
06.02.25		TecDAX-Handel aktuell: TecDAX legt zum Start zu
05.02.25		TecDAX aktuell: TecDAX letztendlich mit Gewinnen
05.02.25		MDAX aktuell: MDAX beendet den Handel in der Gewinnzone
05.02.25		Freundlicher Handel in Frankfurt: MDAX-Börsianer greifen nachmittags zu
05.02.25		Starker Wochentag in Frankfurt: TecDAX klettert am Mittwochnachmittag
05.02.25		Optimismus in Frankfurt: Das macht der MDAX am Mittwochmittag

06.02.25

Handel in Frankfurt: TecDAX auf grünem Terrain

06.02.25

Gewinne in Frankfurt: MDAX mittags mit grünem Vorzeichen

06.02.25

TecDAX-Handel aktuell: TecDAX legt zum Start zu

05.02.25

TecDAX aktuell: TecDAX letztendlich mit Gewinnen

05.02.25

MDAX aktuell: MDAX beendet den Handel in der Gewinnzone

05.02.25

Freundlicher Handel in Frankfurt: MDAX-Börsianer greifen nachmittags zu